TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)Stock · Health Care$17.41+$0.00 (+0.00%)as of market close, Aug 13, 2026
☾ After hours:$17.39+0.00%3:59 PM ET
TAK — Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) stock price, chart and key statistics
Key stats#
Price data
- Price
- $17.41
- Change YTD
- +11.67%
- Market cap
- 54.8B
- Enterprise value
- 78.6B
- Shares outstanding
- 3.2B
- 52W low
- $12.99
- 52W high
- $18.90
- From 52W high
- -7.88%
- From 52W low
- +34.03%
- 52W range
- 75%
- Beta
- -0.08
Volume
- Rel volume
- 0.48×
- 30D volume
- 3.8M
- 30D $ vol
- 65M
Fundamentals
- Sales (ttm)
- 29.8B
- Sales/share
- $9.45
- EPS (ttm)
- -$0.32
- FCF (ttm)
- 6.9B
- FCF/share
- $2.19
- Book value/share
- $14.86
- Net margin
- -3.38%
- ROE
- -2.15%
- ROA
- -1.03%
- Debt / equity
- 0.59×
- Current ratio
- 1.09
Growth (CAGR, ttm) · 10Y
- Sales
- n/a
- Net income
- n/a
- Shares
- n/a
Per-share growth (CAGR, ttm) · 10Y
- EPS
- n/a
- Sales/share
- n/a
- Book value/share
- n/a
- Dividend/share
- n/a
- Price
- -3.04%
- Total return
- +0.20%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- 1334.6×
- Fwd P/E
- 33.0×
- 1.8×
- 1.2×
- 8.0×
- EV/EBITDA (fy)
- 16.4×
- EV/Sales (ttm)
- 2.6×
- 12.55%
- 3.77%
- Dividend/share (fwd)
- $0.66
- 0.61%
- 4.37%
Vs own 10Y history
- P/E
- 88th
- P/OI
- 99th
- P/S
- 66th
- P/B
- 66th
Bar = where today's multiple sits in TAK's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return#
1D
+0.00%
1W
+2.29%
1M
+5.84%
3M
+4.63%
YTD
+11.67%
1Y
+19.00%
5Y
+4.94%
Financial statements
Open full TAK financials →Related Health Care#
1MTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) trades at $17.41 with a live price and an interactive chart covering 16+ years of daily price history, plus key valuation metrics. ChartRow also publishes TAK's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full TAK financial statements →